Comparison Between RTX (Biphasic Cuirass Ventilator) and Physiotherapy in Cystic Fibrosis Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2009 by Hadassah Medical Organization.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00908505
First received: May 19, 2009
Last updated: May 26, 2009
Last verified: May 2009

May 19, 2009
May 26, 2009
July 2009
July 2011   (final data collection date for primary outcome measure)
Pulmonary function test [ Time Frame: 1 hour ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00908505 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Comparison Between RTX (Biphasic Cuirass Ventilator) and Physiotherapy in Cystic Fibrosis Patients
Comparison Between bi-Phasic Negative Pressure Ventilator Therapy and Physiotherapy in Cystic Fibrosis Patients

The purpose of this study is to compare the effectiveness of different mucous clearance techniques in cystic fibrosis patients

Cystic fibrosis (CF) is associated with chronic progressive lung disease that may lead to respiratory failure.Bi-Phasic Cuirass Ventilation (BPCV) is a form of non-invasive respiratory support, which can provide negative pressure ventilation as well as high frequency chest wall oscillations and cough mode.The standard therapy for CF patients to release mucous is treatment by a physiotherapist. In this study we will compare the effect of BPCV with regular physiotherapy by full pulmonary function testing prior and post treatment.

Interventional
Not Provided
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Cystic Fibrosis
Procedure: physiotherapy
physiotherapy either by biphasic cuirass ventilator or physiotherapist
Experimental: physiotherapy
Intervention: Procedure: physiotherapy
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
40
December 2011
July 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • CF patients over 7 years old

Exclusion Criteria:

  • Hemoptysis
  • Pregnancy
Both
7 Years and older
No
Contact: David Shoseyov, MD 972-2-5844430 shoseyov@hadassah.org.il
Contact: Hadas Lemberg, PhD 972 2 6777572 lhadas@hadassah.org.il
Israel
 
NCT00908505
RTX- HMO-CTIL
No
Arik Tzukert, DMD, Hadassah Medical Organization, Jerusalem, Israel
Hadassah Medical Organization
Not Provided
Principal Investigator: David Shoseyov, MD Hadassah Medical Organization
Hadassah Medical Organization
May 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP